Anavex生命科学公司（Anavex Life Sciences Corp.）董事会宣布一项重要人事任命：公司前临床开发高级副总裁Terrie Kellmeyer博士已被任命为临时首席执行官。
此项任命标志着公司在领导层过渡期间，将依靠Kellmeyer博士在临床开发领域的深厚专业知识来指导公司战略。Kellmeyer博士此前在Anavex担任高级副总裁期间，在推动公司临床项目方面发挥了关键作用。
董事会相信，凭借其丰富的经验和对公司研发管线的深刻理解，Kellmeyer博士将能有效领导公司度过这一时期，并确保核心业务运营的连续性与稳定性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.